The diagnostic wearable medical devices market size has grown rapidly in recent years. It will grow from $8.09 billion in 2025 to $9.18 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to limited availability of wearable medical devices, high cost of early devices, reliance on traditional monitoring methods, growing awareness of health and fitness tracking, limited integration with mobile apps.
The diagnostic wearable medical devices market size is expected to see rapid growth in the next few years. It will grow to $15.01 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to technological advancements in sensors and wearable electronics, rising demand for remote patient monitoring, growing adoption of home healthcare solutions, integration with ai and cloud platforms, expansion of wearable use in fetal and neuro monitoring. Major trends in the forecast period include rising adoption of remote patient monitoring, increasing use of wearables in sports and fitness, growth in home healthcare monitoring, integration with mobile health applications, enhanced focus on continuous and real-time health tracking.
The increasing prevalence of chronic diseases is anticipated to support the expansion of the diagnostic wearable medical devices market going forward. Chronic diseases are long-term health conditions that develop gradually, persist over extended periods, and often require continuous management. Their growing prevalence is influenced by aging populations, sedentary lifestyles, unhealthy diets, rising obesity rates, and increased exposure to risk factors such as smoking and excessive alcohol consumption. Diagnostic wearable medical devices are increasingly adopted to manage chronic conditions by monitoring vital signs and health metrics in real time, enabling better disease management by patients and healthcare providers. For example, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 194 million US adults, or 76.4%, reported having at least one chronic condition in 2023. As a result, the increasing prevalence of chronic diseases is reinforcing growth in the diagnostic wearable medical devices market.
Leading companies operating in the diagnostic wearable medical devices market are focused on developing innovative solutions, such as glucose monitoring systems, to improve accuracy, enhance user experience, and support the management of chronic conditions including diabetes. Glucose monitoring systems are medical devices that measure and track blood glucose levels, enabling individuals to manage diabetes using real-time data and actionable insights. For example, in February 2023, Dexcom Inc., a US-based manufacturer of continuous glucose monitoring systems, introduced the next-generation Dexcom G7 CGM System for Medicare beneficiaries. This system features a smaller and more discreet design, faster warm-up time, and an integrated sensor-transmitter unit that enhances usability and accuracy, achieving an overall mean absolute relative difference (MARD) of 8.2%. It also provides customizable alerts, extended wear duration, and integration with digital health platforms and diabetes management devices.
In January 2024, Boston Scientific, a US-based global medical technology company, announced an agreement to acquire Axonics, Inc. for an undisclosed amount. The primary objective of this acquisition is to strengthen Boston Scientific’s urology portfolio by integrating Axonics’ innovative devices for treating urinary and bowel dysfunction, particularly through sacral neuromodulation therapies. Axonics, Inc. is a US-based medical technology company.
Major companies operating in the diagnostic wearable medical devices market are Apple Inc., Google LLC, Samsung Electronics Co. Ltd., Huawei Technologies Co. Ltd., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Medtronic plc, Koninklijke Philips NV, GE Healthcare, OMRON Corporation, Garmin Ltd., Drägerwerk AG & Co. KGaA, Molex LLC, ResMed Inc., Dexcom Inc., Boyd Corporation, Masimo Corporation, AliveCor Inc., VitalConnect Inc., BTS Bioengineering Corp., Cleveland Medical Devices Inc., Meril Life Sciences Pvt. Ltd., Activinsights Ltd., Murata Vios Inc.
North America was the largest region in the diagnostic wearable medical devices market in 2025. The regions covered in the diagnostic wearable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diagnostic wearable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the diagnostic wearable medical devices market by increasing the cost of imported sensors, electronics, and components used in wearable devices. Segments such as ECG monitors, neuro monitoring wearables, and fetal monitoring devices are particularly impacted, with regions like China and Southeast Asia facing higher import duties. This has led to increased product costs and slower adoption in price-sensitive markets. However, tariffs have also encouraged local manufacturing, innovation in sensor technologies, and investment in domestic production, which could strengthen regional supply chains.
The diagnostic wearable medical devices market research report is one of a series of new reports that provides diagnostic wearable medical devices market statistics, including diagnostic wearable medical devices industry global market size, regional shares, competitors with a diagnostic wearable medical devices market share, detailed diagnostic wearable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic wearable medical devices industry. This diagnostic wearable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Diagnostic wearable medical devices are electronic devices worn on the body that continuously monitor health data to help detect and diagnose medical conditions. They track vital signs, identify abnormalities, and provide real-time insights that support early diagnosis and personalized treatment.
The main categories of diagnostic wearable medical devices include vital signs monitors, sleep and activity monitors, fetal and obstetric monitoring devices, neuro monitoring devices, and electrocardiogram monitors. Vital signs monitors track key health parameters such as heart rate, blood pressure, and oxygen saturation. These devices are widely used in hospitals and home settings to observe patient health conditions and identify critical changes in vital signs. The distribution channels include online platforms, pharmacies, and hypermarkets, and the applications include sports and fitness, remote patient monitoring, and home healthcare.
The diagnostic wearable medical devices market consists of sales of fitness trackers, smartwatches, heart rate monitors, and blood glucose monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The diagnostic wearable medical devices market size is expected to see rapid growth in the next few years. It will grow to $15.01 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to technological advancements in sensors and wearable electronics, rising demand for remote patient monitoring, growing adoption of home healthcare solutions, integration with ai and cloud platforms, expansion of wearable use in fetal and neuro monitoring. Major trends in the forecast period include rising adoption of remote patient monitoring, increasing use of wearables in sports and fitness, growth in home healthcare monitoring, integration with mobile health applications, enhanced focus on continuous and real-time health tracking.
The increasing prevalence of chronic diseases is anticipated to support the expansion of the diagnostic wearable medical devices market going forward. Chronic diseases are long-term health conditions that develop gradually, persist over extended periods, and often require continuous management. Their growing prevalence is influenced by aging populations, sedentary lifestyles, unhealthy diets, rising obesity rates, and increased exposure to risk factors such as smoking and excessive alcohol consumption. Diagnostic wearable medical devices are increasingly adopted to manage chronic conditions by monitoring vital signs and health metrics in real time, enabling better disease management by patients and healthcare providers. For example, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 194 million US adults, or 76.4%, reported having at least one chronic condition in 2023. As a result, the increasing prevalence of chronic diseases is reinforcing growth in the diagnostic wearable medical devices market.
Leading companies operating in the diagnostic wearable medical devices market are focused on developing innovative solutions, such as glucose monitoring systems, to improve accuracy, enhance user experience, and support the management of chronic conditions including diabetes. Glucose monitoring systems are medical devices that measure and track blood glucose levels, enabling individuals to manage diabetes using real-time data and actionable insights. For example, in February 2023, Dexcom Inc., a US-based manufacturer of continuous glucose monitoring systems, introduced the next-generation Dexcom G7 CGM System for Medicare beneficiaries. This system features a smaller and more discreet design, faster warm-up time, and an integrated sensor-transmitter unit that enhances usability and accuracy, achieving an overall mean absolute relative difference (MARD) of 8.2%. It also provides customizable alerts, extended wear duration, and integration with digital health platforms and diabetes management devices.
In January 2024, Boston Scientific, a US-based global medical technology company, announced an agreement to acquire Axonics, Inc. for an undisclosed amount. The primary objective of this acquisition is to strengthen Boston Scientific’s urology portfolio by integrating Axonics’ innovative devices for treating urinary and bowel dysfunction, particularly through sacral neuromodulation therapies. Axonics, Inc. is a US-based medical technology company.
Major companies operating in the diagnostic wearable medical devices market are Apple Inc., Google LLC, Samsung Electronics Co. Ltd., Huawei Technologies Co. Ltd., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Medtronic plc, Koninklijke Philips NV, GE Healthcare, OMRON Corporation, Garmin Ltd., Drägerwerk AG & Co. KGaA, Molex LLC, ResMed Inc., Dexcom Inc., Boyd Corporation, Masimo Corporation, AliveCor Inc., VitalConnect Inc., BTS Bioengineering Corp., Cleveland Medical Devices Inc., Meril Life Sciences Pvt. Ltd., Activinsights Ltd., Murata Vios Inc.
North America was the largest region in the diagnostic wearable medical devices market in 2025. The regions covered in the diagnostic wearable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diagnostic wearable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the diagnostic wearable medical devices market by increasing the cost of imported sensors, electronics, and components used in wearable devices. Segments such as ECG monitors, neuro monitoring wearables, and fetal monitoring devices are particularly impacted, with regions like China and Southeast Asia facing higher import duties. This has led to increased product costs and slower adoption in price-sensitive markets. However, tariffs have also encouraged local manufacturing, innovation in sensor technologies, and investment in domestic production, which could strengthen regional supply chains.
The diagnostic wearable medical devices market research report is one of a series of new reports that provides diagnostic wearable medical devices market statistics, including diagnostic wearable medical devices industry global market size, regional shares, competitors with a diagnostic wearable medical devices market share, detailed diagnostic wearable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic wearable medical devices industry. This diagnostic wearable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Diagnostic wearable medical devices are electronic devices worn on the body that continuously monitor health data to help detect and diagnose medical conditions. They track vital signs, identify abnormalities, and provide real-time insights that support early diagnosis and personalized treatment.
The main categories of diagnostic wearable medical devices include vital signs monitors, sleep and activity monitors, fetal and obstetric monitoring devices, neuro monitoring devices, and electrocardiogram monitors. Vital signs monitors track key health parameters such as heart rate, blood pressure, and oxygen saturation. These devices are widely used in hospitals and home settings to observe patient health conditions and identify critical changes in vital signs. The distribution channels include online platforms, pharmacies, and hypermarkets, and the applications include sports and fitness, remote patient monitoring, and home healthcare.
The diagnostic wearable medical devices market consists of sales of fitness trackers, smartwatches, heart rate monitors, and blood glucose monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Diagnostic Wearable Medical Devices Market Characteristics
3. Diagnostic Wearable Medical Devices Market Supply Chain Analysis
4. Global Diagnostic Wearable Medical Devices Market Trends and Strategies
5. Diagnostic Wearable Medical Devices Market Analysis of End Use Industries
7. Global Diagnostic Wearable Medical Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Diagnostic Wearable Medical Devices Total Addressable Market (TAM) Analysis for the Market
9. Diagnostic Wearable Medical Devices Market Segmentation
10. Diagnostic Wearable Medical Devices Market Regional and Country Analysis
11. Asia-Pacific Diagnostic Wearable Medical Devices Market
12. China Diagnostic Wearable Medical Devices Market
13. India Diagnostic Wearable Medical Devices Market
14. Japan Diagnostic Wearable Medical Devices Market
15. Australia Diagnostic Wearable Medical Devices Market
16. Indonesia Diagnostic Wearable Medical Devices Market
17. South Korea Diagnostic Wearable Medical Devices Market
18. Taiwan Diagnostic Wearable Medical Devices Market
19. South East Asia Diagnostic Wearable Medical Devices Market
20. Western Europe Diagnostic Wearable Medical Devices Market
21. UK Diagnostic Wearable Medical Devices Market
22. Germany Diagnostic Wearable Medical Devices Market
23. France Diagnostic Wearable Medical Devices Market
24. Italy Diagnostic Wearable Medical Devices Market
25. Spain Diagnostic Wearable Medical Devices Market
26. Eastern Europe Diagnostic Wearable Medical Devices Market
27. Russia Diagnostic Wearable Medical Devices Market
28. North America Diagnostic Wearable Medical Devices Market
29. USA Diagnostic Wearable Medical Devices Market
30. Canada Diagnostic Wearable Medical Devices Market
31. South America Diagnostic Wearable Medical Devices Market
32. Brazil Diagnostic Wearable Medical Devices Market
33. Middle East Diagnostic Wearable Medical Devices Market
34. Africa Diagnostic Wearable Medical Devices Market
36. Diagnostic Wearable Medical Devices Market Competitive Landscape and Company Profiles
37. Diagnostic Wearable Medical Devices Market Other Major and Innovative Companies
40. Diagnostic Wearable Medical Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Diagnostic Wearable Medical Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses diagnostic wearable medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for diagnostic wearable medical devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic wearable medical devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Vital Signs Monitor; Sleep And Activity Monitor; Fetal And Obstetric Monitoring; Neuro Monitoring; Electrocardiogram Monitors2) By Channel: Online; Pharmacies; Hypermarkets
3) By Application: Sports And Fitness; Remote Patient Monitoring; Home Healthcare
Subsegments:
1) By Vital Signs Monitor: Heart Rate Monitor; Blood Pressure Monitor; Temperature Monitor; Respiratory Rate Monitor; Blood Oxygen Saturation (Spo2) Monitor2) By Sleep And Activity Monitor: Sleep Apnea Monitor; Wearable Sleep Trackers; Physical Activity And Fitness Trackers; Step Counters And Pedometers; Sleep Pattern Monitoring Devices
3) By Fetal And Obstetric Monitoring: Fetal Heart Rate Monitor; Maternal Contraction Monitors; Wearable Pregnancy Monitoring Devices; Non-Invasive Fetal Monitoring Devices
4) By Neuro Monitoring: Wearable EEG Monitors; Brain Activity Monitors; Seizure Monitoring Devices; Wearable Neurostimulation Devices
5) By Electrocardiogram Monitors: Portable ECG Monitors; Wearable ECG Patches; Real-Time ECG Monitoring Devices; Continuous ECG Monitoring Wearables
Companies Mentioned: Apple Inc.; Google LLC; Samsung Electronics Co. Ltd.; Huawei Technologies Co. Ltd.; F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Medtronic plc; Koninklijke Philips NV; GE Healthcare; OMRON Corporation; Garmin Ltd.; Drägerwerk AG & Co. KGaA; Molex LLC; ResMed Inc.; Dexcom Inc.; Boyd Corporation; Masimo Corporation; AliveCor Inc.; VitalConnect Inc.; BTS Bioengineering Corp.; Cleveland Medical Devices Inc.; Meril Life Sciences Pvt. Ltd.; Activinsights Ltd.; Murata Vios Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Diagnostic Wearable Medical Devices market report include:- Apple Inc.
- Google LLC
- Samsung Electronics Co. Ltd.
- Huawei Technologies Co. Ltd.
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Medtronic plc
- Koninklijke Philips NV
- GE Healthcare
- OMRON Corporation
- Garmin Ltd.
- Drägerwerk AG & Co. KGaA
- Molex LLC
- ResMed Inc.
- Dexcom Inc.
- Boyd Corporation
- Masimo Corporation
- AliveCor Inc.
- VitalConnect Inc.
- BTS Bioengineering Corp.
- Cleveland Medical Devices Inc.
- Meril Life Sciences Pvt. Ltd.
- Activinsights Ltd.
- Murata Vios Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.18 Billion |
| Forecasted Market Value ( USD | $ 15.01 Billion |
| Compound Annual Growth Rate | 13.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
